Nanobiotix
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Nanobiotix and buy or sell other stocks, ETFs, and their options commission-free!About NBTX
Nanobiotix SA is a late-stage biotechnology company, which engages in the development of therapeutic approaches to the treatment of cancer. Its technologies include NanoXray that improves the efficacy of radiation therapy against tumor cells.
CEOLaurent Lévy
CEOLaurent Lévy
Employees108
Employees108
HeadquartersParis, Ile-de-France
HeadquartersParis, Ile-de-France
Founded2003
Founded2003
Employees108
Employees108
NBTX Key Statistics
Market cap787.82M
Market cap787.82M
Price-Earnings ratio-18.13
Price-Earnings ratio-18.13
Dividend yield—
Dividend yield—
Average volume104.45K
Average volume104.45K
High today$16.98
High today$16.98
Low today$14.00
Low today$14.00
Open price$14.46
Open price$14.46
Volume129.92K
Volume129.92K
52 Week high$16.98
52 Week high$16.98
52 Week low$2.76
52 Week low$2.76
NBTX News
TipRanks 5d
Nanobiotix price target raised to EUR 13 from EUR 10 at H.C. WainwrightH.C. Wainwright raised the firm’s price target on Nanobiotix (NBTX) to EUR 13 from EUR 10 and keeps a Buy rating on the shares. The company announced positive r...
Benzinga 6d
Melanoma Data Study Boosts J&J Partner Nanobiotix Stock On ThursdayNanobiotix SA NBTX announced new results focused on patients with primary cutaneous melanoma from an ongoing Phase 1 Study. 1100 evaluating JNJ-1900 (NBTXR3) i...
Benzinga 6d
Radian Group, Intel, Nanobiotix, CrowdStrike And Other Big Stocks Moving Higher On ThursdayU.S. stocks were higher, with the Nasdaq Composite gaining more than 200 points on Thursday. Shares of Radian Group Inc. RDN rose sharply during Thursday's ses...
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
More NBTX News
Seeking Alpha 7d
Nanobiotix soars on positive phase 1 results for JNJ-1900 in melanomaNanobiotix (NASDAQ:NBTX) shares rose sharply in Thursday's premarket trading after the company announced new Phase 1 study results for JNJ-1900 in melanoma. Th...
